Wordt geladen...
Resistance to Integrase Inhibitors
Integrase (IN) is a clinically validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clinical activity. The next most advanced IN inhibitor is elvitegravir. However, mutant viruses lead to treatment failure and mutations within the IN codin...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Molecular Diversity Preservation International (MDPI)
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2920056/ https://ncbi.nlm.nih.gov/pubmed/20706558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v2071347 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|